Just recently, the LRRK2 G2019S mutation has been shown to inhibit the degradation of α-syn in an in vitro model of PD (Hu et al., 2018) and disrupts mitochondrial depletion via mitophagy (Hsieh et al., 2016). The gene discussed is LRRK2; the disease is Parkinson disease.